• MindMed (MMED) announced the appointment of David Endicott and Linnea Burman to its Board of Directors, effective June 29, 2026, expanding the Board from nine to 11 members.
  • This development provides a company-specific catalyst for the 4.3% rise in MMED's stock price today.
  • The broader market is also trending higher, with the NASDAQ up 1.13% and the S&P 500 reporting gains between 0.54% and 1.1% across various sources.